Latest news Iris Capital Investment January 24, 2025 Median Technologies Secures up to €10 million equity line completed with IRIS to enable 2025 EIB loan Read more December 17, 2024 THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE AN AGREEMENT LICENSE FOR THE MARKETING OF THERANEXUS TX01 IN THE TREATMENT OF TWO RARE NEUROLOGICAL DISEASES Read more October 16, 2024 Establishment of a renewable equity financing line of a maximum amount of €2 million to support the ramp-up of the Revin industrial site Read more September 30, 2024 Poxel Announces Agreement with OrbiMed to Monetize a portion of TWYMEEG Royalties for USD 50 million Read more September 30, 2024 TheraVet announces a strategic transformation project aimed at creating a leader in human idiopathic pulmonary fibrosis Read more August 7, 2024 Sumitomo Pharma and Poxel AnnounceTopline Results from Post-MarketingClinical Study on TWYMEEG® for the Treatment of Type 2 Diabetes in Japan Read more July 11, 2024 Theranexus – Implementation of a new equity line up to €2.5 Millions Read more July 11, 2024 Kalray – New financing secured up to €10 millions Read more February 14, 2024 New capital increase at Temisis with Société Financière Hoche Bains les Bains (SFHBB) Read more February 13, 2024 Plant Advanced Technologies PAT is setting up an equity financing line of a maximum amount of 1 million euros with Iris. Read more November 20, 2023 TheraVet announces the setting up of an equity-linked financing facility and updates on its financing strategy Read more July 13, 2023 THERANEXUS raises around 3.1 million euros in fundraising Read more May 24, 2023 ABIONYX Pharma accelerates its development by launching a new biomanufacturing campaign based Read more March 23, 2023 Poxel Reports Financial Results for Full Year 2022 and Provides Corporate Update Read more December 16, 2022 Cibox annouces Establishment of a financing line for a maximum amount of €2 million in the context of the implementation of the electric bicycle manufacturing plant project in France Read more August 8, 2022 Poxel Announces Extended Cash Runway with Debt Restructuring Agreement Read more July 28, 2022 Spexis provides business update Read more May 2, 2022 MAGNUM Secures Funding Facility Read more January 21, 2022 ENERGISME has announced the establishment of a line of equity financing Read more January 21, 2022 THERANEXUS Publishes its cash position as of 31 december 2021 Read more July 28, 2021 CIBOX – Setting up a financing line of up to € 1.5 million to initiate the acceleration of development in electric mobility Read more May 25, 2021 BOOSTHEAT announces new funding in the form of an Equity Line with IRIS, up to €10 million, renewable twice Read more March 22, 2021 Hybrigenics announces the implementation of an equity financing line. Read more January 19, 2021 Theranexus implements a new equity line of an amount of up to €8.4 million in total over 12 months Read more December 22, 2020 Cerinnov Group announces the implementation of an equity line of an amount of €2 million Read more July 28, 2020 Polyphor Strengthens financial flexibility with CHF 19.3 million equity-linked financing Read more July 9, 2020 Theranexus implements a Mandatory Convertible Bond facility Read more April 29, 2020 Bone Therapeutics secures EUR 11 million financing Read more April 8, 2020 Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million Read more December 5, 2019 DMS enters into a EUR 4 million Mandatory Convertible Bond facility, convertible into DMS or Hybrigenics shares Read more
